Teva Pharmaceutical has its hands full trying to finalize its $40.5 billion buyout of Allergan’s generics business, a deal it expects to close this week. But…

Sagent Pharmaceuticals will soon have a new Japanese owner, but for now any recalls are all on the U.S. injectable drug manufacturer. And it has another recall…

A Genzyme manufacturing site in Ireland is getting a new name, some new products and more than three dozen new jobs.

Noven has been recalling tens of thousands of boxes of its Daytrana patches from the market because of issues over peeling away a protective liner to deliver…

Epilepsy patients in Canada are scrambling to find supplies of seizure drug clobazam after a supply interruptions at Canada’s largest drug company and another…

India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player.

China has signed off on Switzerland-based Siegfried’s new contract manufacturing plant in Nantong, and after 10 months of trial operation, the facility is open…

Pfizer will build a biologics plant in China, where it will make biosimilars for the Chinese market but also for sale throughout the world.